GB201718285D0 - Antibacterial Compounds - Google Patents
Antibacterial CompoundsInfo
- Publication number
- GB201718285D0 GB201718285D0 GBGB1718285.8A GB201718285A GB201718285D0 GB 201718285 D0 GB201718285 D0 GB 201718285D0 GB 201718285 A GB201718285 A GB 201718285A GB 201718285 D0 GB201718285 D0 GB 201718285D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- antibacterial compounds
- antibacterial
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Warehouses Or Storage Devices (AREA)
Priority Applications (30)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1718285.8A GB201718285D0 (en) | 2017-11-03 | 2017-11-03 | Antibacterial Compounds |
| ES18800297T ES3005164T3 (en) | 2017-11-03 | 2018-11-02 | Antibacterial compounds |
| UAA202003341A UA128475C2 (uk) | 2017-11-03 | 2018-11-02 | Антибактеріальні сполуки |
| CN201880085171.5A CN111566099B (zh) | 2017-11-03 | 2018-11-02 | 抗菌化合物 |
| GEAP202315801A GEAP202315801A (en) | 2017-11-03 | 2018-11-02 | Antibacterial compounds |
| EA202091118A EA202091118A1 (ru) | 2017-11-03 | 2018-11-02 | Антибактериальные соединения |
| AU2018361828A AU2018361828B2 (en) | 2017-11-03 | 2018-11-02 | Antibacterial compounds |
| PCT/GB2018/053183 WO2019086890A1 (en) | 2017-11-03 | 2018-11-02 | Antibacterial compounds |
| JP2020524275A JP7348897B2 (ja) | 2017-11-03 | 2018-11-02 | 抗菌性化合物 |
| US16/761,016 US11345694B2 (en) | 2017-11-03 | 2018-11-02 | Antibacterial compounds |
| NZ764310A NZ764310B2 (en) | 2018-11-02 | Antibacterial compounds | |
| PE2020000454A PE20211390A1 (es) | 2017-11-03 | 2018-11-02 | Compuestos antibacterianos |
| PE2022000118A PE20221006A1 (es) | 2017-11-03 | 2018-11-02 | Compuestos antibacterianos para el tratamiento de la enfermedad de la bacteriana por "enterobacteriaceae" |
| SG11202003717UA SG11202003717UA (en) | 2017-11-03 | 2018-11-02 | Antibacterial compounds |
| MA050504A MA50504A (fr) | 2017-11-03 | 2018-11-02 | Composés antibactériens |
| KR1020207015574A KR102470319B1 (ko) | 2017-11-03 | 2018-11-02 | 항균성 화합물 |
| MX2020004562A MX2020004562A (es) | 2017-11-03 | 2018-11-02 | Compuestos antibacterianos. |
| EP18800297.6A EP3704105B9 (en) | 2017-11-03 | 2018-11-02 | Antibacterial compounds |
| BR112020008531-6A BR112020008531A2 (pt) | 2017-11-03 | 2018-11-02 | compostos antibacterianos |
| EP24200101.4A EP4606375A3 (en) | 2017-11-03 | 2018-11-02 | Antibacterial compounds |
| GEAP201815801A GEP20237522B (en) | 2017-11-03 | 2018-11-02 | Antibacterial compounds |
| CA3081423A CA3081423A1 (en) | 2017-11-03 | 2018-11-02 | Antibacterial compounds |
| IL274229A IL274229B2 (en) | 2017-11-03 | 2020-04-26 | Antibacterial compounds |
| CL2020001147A CL2020001147A1 (es) | 2017-11-03 | 2020-04-30 | Compuestos antibacterianos |
| CONC2020/0005420A CO2020005420A2 (es) | 2017-11-03 | 2020-04-30 | Compuestos antibacterianos |
| ZA2020/02093A ZA202002093B (en) | 2017-11-03 | 2020-05-04 | Antibacterial compounds |
| MX2021010246A MX2021010246A (es) | 2017-11-03 | 2020-07-13 | Compuestos antibacterianos. |
| CL2021002263A CL2021002263A1 (es) | 2017-11-03 | 2021-08-27 | Compuestos antibacterianos (solicitud divisional 202001147) |
| JP2021178557A JP2022025116A (ja) | 2017-11-03 | 2021-11-01 | 抗菌性化合物 |
| US17/728,335 US20220372027A1 (en) | 2017-11-03 | 2022-04-25 | Antibacterial compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1718285.8A GB201718285D0 (en) | 2017-11-03 | 2017-11-03 | Antibacterial Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201718285D0 true GB201718285D0 (en) | 2017-12-20 |
Family
ID=60664899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1718285.8A Ceased GB201718285D0 (en) | 2017-11-03 | 2017-11-03 | Antibacterial Compounds |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US11345694B2 (https=) |
| EP (2) | EP4606375A3 (https=) |
| JP (2) | JP7348897B2 (https=) |
| KR (1) | KR102470319B1 (https=) |
| CN (1) | CN111566099B (https=) |
| AU (1) | AU2018361828B2 (https=) |
| BR (1) | BR112020008531A2 (https=) |
| CA (1) | CA3081423A1 (https=) |
| CL (2) | CL2020001147A1 (https=) |
| CO (1) | CO2020005420A2 (https=) |
| EA (1) | EA202091118A1 (https=) |
| ES (1) | ES3005164T3 (https=) |
| GB (1) | GB201718285D0 (https=) |
| GE (2) | GEAP202315801A (https=) |
| IL (1) | IL274229B2 (https=) |
| MA (1) | MA50504A (https=) |
| MX (2) | MX2020004562A (https=) |
| PE (2) | PE20221006A1 (https=) |
| SG (1) | SG11202003717UA (https=) |
| UA (1) | UA128475C2 (https=) |
| WO (1) | WO2019086890A1 (https=) |
| ZA (1) | ZA202002093B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201718285D0 (en) * | 2017-11-03 | 2017-12-20 | Discuva Ltd | Antibacterial Compounds |
| HRP20240793T1 (hr) | 2018-04-18 | 2024-09-13 | Constellation Pharmaceuticals, Inc. | Modulatori enzima koji modificiraju metil, njihovi pripravci i upotreba |
| EP3797108B1 (en) | 2018-05-21 | 2022-07-20 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| LT4003532T (lt) | 2019-07-24 | 2024-11-11 | Constellation Pharmaceuticals, Inc. | 7-chlor-2- (4-(3-metoksiazetidin-1-il)cikloheksil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-okso-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioksol-5-karboksamido kristalinės formos |
| CN111635372B (zh) * | 2020-06-28 | 2022-05-27 | 齐鲁工业大学 | 一种恶唑酮衍生物及其合成方法 |
| CN117545485A (zh) * | 2021-05-03 | 2024-02-09 | 迪斯库瓦有限公司 | 抗菌化合物 |
| AU2022270347B2 (en) * | 2021-05-03 | 2025-09-25 | Discuva Limited | Antibacterial compound |
| US20250161980A1 (en) | 2022-02-21 | 2025-05-22 | Mitsui Chemicals, Inc. | Metal member, metal-resin composite body, and method for producing metal member |
| CN118164937A (zh) * | 2024-03-13 | 2024-06-11 | 北京联本医药化学技术有限公司 | 一种铵盐离子液体催化制备5-乙酰基-2,3-苯丙二氢呋喃的方法 |
| CN120208965B (zh) * | 2025-05-28 | 2025-08-12 | 四川大学 | 靶向革兰氏阴性菌外膜组装关键蛋白质机器的4-(吡啶-4-基)-1h-咪唑-2-胺类衍生物、组合物 |
| CN121471219A (zh) * | 2026-01-09 | 2026-02-06 | 四川大学 | 用于革兰氏阴性菌特异性抗菌治疗的咪唑-2-胺类衍生物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA869348B (en) | 1985-12-12 | 1987-10-28 | Smithkline Beckman Corp | Inhibition of the 5-lipoxygenase pathway |
| US4780470A (en) * | 1986-08-19 | 1988-10-25 | Smithkline Beckman Corporation | Inhibition of interleukin-1 by monocytes and/or macrophages |
| JP2808460B2 (ja) * | 1989-11-16 | 1998-10-08 | 大正製薬株式会社 | イミダゾール誘導体 |
| JPH09124640A (ja) | 1995-08-25 | 1997-05-13 | Nippon Soda Co Ltd | ピリジルイミダゾール化合物、製法および農園芸用殺菌剤 |
| US6207687B1 (en) | 1998-07-31 | 2001-03-27 | Merck & Co., Inc. | Substituted imidazoles having cytokine inhibitory activity |
| CO5271680A1 (es) * | 2000-02-21 | 2003-04-30 | Smithkline Beecham Corp | Compuestos |
| AU2003249977A1 (en) * | 2002-07-05 | 2004-01-23 | Axxima Pharmaceuticals Ag | Imidazole compounds for the treatment of hepatitis c virus infections |
| JP2004196678A (ja) | 2002-12-17 | 2004-07-15 | Dainippon Pharmaceut Co Ltd | ピラゾール系誘導体 |
| CA2545942C (en) | 2003-11-14 | 2012-07-10 | Lorus Therapeutics Inc. | Aryl imidazoles and their use as anti-cancer agents |
| RU2367661C2 (ru) | 2004-03-05 | 2009-09-20 | Тайсо Фармасьютикал Ко., Лтд. | Производные тиазола |
| JP2007277230A (ja) * | 2006-03-15 | 2007-10-25 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| US8865732B2 (en) | 2008-03-21 | 2014-10-21 | Novartis Ag | Heterocyclic compounds and uses thereof |
| WO2011080132A2 (en) | 2009-12-17 | 2011-07-07 | Katholieke Universiteit Leuven, K.U. Leuven R&D | Compounds, compositions and methods for controlling biofilms |
| GB201016261D0 (en) | 2010-09-28 | 2010-11-10 | Univ Leuven Kath | Compounds for controlling biofilms and process for their production |
| WO2012135016A2 (en) | 2011-03-25 | 2012-10-04 | North Carolina State University | Inhibition of bacterial biofilms and microbial growth with imidazole derivatives |
| AU2012281281B2 (en) | 2011-07-13 | 2017-06-01 | Tiumbio Co., Ltd | 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| US8840912B2 (en) | 2012-01-09 | 2014-09-23 | North Carolina State University | Imidazole derivatives useful for controlling microbial growth |
| CN113398271A (zh) * | 2014-05-16 | 2021-09-17 | 归属疗法有限公司 | 抗流感病毒和金黄色葡萄球菌合并感染的新型抗感染策略 |
| EA037112B1 (ru) | 2015-03-02 | 2021-02-08 | Ригель Фармасьютикалс, Инк. | Ингибиторы tgf- |
| WO2016141381A2 (en) | 2015-03-05 | 2016-09-09 | University Of Notre Dame Du Lac | Potentiators of beta-lactam antibiotics |
| CA3030582A1 (en) | 2015-07-22 | 2017-01-26 | The Royal Institution For The Advancement Of Learning/Mcgill University | Compounds and uses thereof in the treatment of cancers and other medical conditions |
| GB201718285D0 (en) * | 2017-11-03 | 2017-12-20 | Discuva Ltd | Antibacterial Compounds |
-
2017
- 2017-11-03 GB GBGB1718285.8A patent/GB201718285D0/en not_active Ceased
-
2018
- 2018-11-02 ES ES18800297T patent/ES3005164T3/es active Active
- 2018-11-02 WO PCT/GB2018/053183 patent/WO2019086890A1/en not_active Ceased
- 2018-11-02 EP EP24200101.4A patent/EP4606375A3/en active Pending
- 2018-11-02 UA UAA202003341A patent/UA128475C2/uk unknown
- 2018-11-02 EA EA202091118A patent/EA202091118A1/ru unknown
- 2018-11-02 PE PE2022000118A patent/PE20221006A1/es unknown
- 2018-11-02 MA MA050504A patent/MA50504A/fr unknown
- 2018-11-02 CN CN201880085171.5A patent/CN111566099B/zh active Active
- 2018-11-02 CA CA3081423A patent/CA3081423A1/en active Pending
- 2018-11-02 EP EP18800297.6A patent/EP3704105B9/en active Active
- 2018-11-02 US US16/761,016 patent/US11345694B2/en active Active
- 2018-11-02 JP JP2020524275A patent/JP7348897B2/ja active Active
- 2018-11-02 MX MX2020004562A patent/MX2020004562A/es unknown
- 2018-11-02 PE PE2020000454A patent/PE20211390A1/es unknown
- 2018-11-02 SG SG11202003717UA patent/SG11202003717UA/en unknown
- 2018-11-02 GE GEAP202315801A patent/GEAP202315801A/en unknown
- 2018-11-02 KR KR1020207015574A patent/KR102470319B1/ko active Active
- 2018-11-02 BR BR112020008531-6A patent/BR112020008531A2/pt active Search and Examination
- 2018-11-02 AU AU2018361828A patent/AU2018361828B2/en active Active
- 2018-11-02 GE GEAP201815801A patent/GEP20237522B/en unknown
-
2020
- 2020-04-26 IL IL274229A patent/IL274229B2/en unknown
- 2020-04-30 CO CONC2020/0005420A patent/CO2020005420A2/es unknown
- 2020-04-30 CL CL2020001147A patent/CL2020001147A1/es unknown
- 2020-05-04 ZA ZA2020/02093A patent/ZA202002093B/en unknown
- 2020-07-13 MX MX2021010246A patent/MX2021010246A/es unknown
-
2021
- 2021-08-27 CL CL2021002263A patent/CL2021002263A1/es unknown
- 2021-11-01 JP JP2021178557A patent/JP2022025116A/ja not_active Withdrawn
-
2022
- 2022-04-25 US US17/728,335 patent/US20220372027A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL256391A (en) | Antibacterial compounds | |
| GB201700814D0 (en) | Compounds | |
| IL274229A (en) | Antibacterial compounds | |
| GB201704327D0 (en) | Compounds | |
| IL263285A (en) | New antibacterial compounds | |
| IL281614A (en) | Antibacterial compounds | |
| GB201704325D0 (en) | Compounds | |
| SG11202011298YA (en) | Antibacterial compounds | |
| GB201702221D0 (en) | Compounds | |
| GB201516614D0 (en) | Antibacterial compounds | |
| GB201711555D0 (en) | Antibacterial compounds | |
| GB201704166D0 (en) | Antibacterial Compounds | |
| GB201602235D0 (en) | Antibacterial compounds | |
| GB201708844D0 (en) | Anti-bacterial compounds | |
| GB201703282D0 (en) | Compounds | |
| GB201704313D0 (en) | Antibacterial compounds | |
| GB201807966D0 (en) | Antibacterial compounds | |
| GB201616460D0 (en) | Antibacterial compounds | |
| GB201616456D0 (en) | Antibacterial compounds | |
| GB201613866D0 (en) | Antibacterial compounds | |
| PT3316969T (pt) | Compostos antibacterianos | |
| GB201602241D0 (en) | Antibacterial compounds | |
| GB201602234D0 (en) | Antibacterial compounds | |
| GB201615829D0 (en) | Antibacterial compounds | |
| GB201704297D0 (en) | Antibacterial agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |